At novavax:
We Focus On You
At Novavax, we are committed to helping protect people from the world’s most challenging infectious diseases. With more than a decade of vaccine innovation and research, we work with one goal in mind: to keep you focused on what matters most.
What diseases have we worked on?
| Seasonal influenza (flu) | Coronavirus | Middle East respiratory syndrome (MERS) |
| Severe acute respiratory syndrome (SARS) | Ebola virus | Respiratory syncytial virus (RSV) |
OUR APPROACH TO TECHNOLOGY MAKES US DIFFERENT
We study and develop solutions for emerging strains of viruses to help protect our future. Our work includes:
Nanoparticle technology
These are particles so small they cannot be seen by the human eye. To the immune system, these nanoparticles look just like a virus, but they don’t have the actual virus in it. We use these nanoparticles to trigger the body’s immune response.
Protein subunit technology
This is a well-known and established technology used to fight against diseases such as seasonal flu, HPV, hepatitis B, and Haemophilus influenzae type B.
Exclusive adjuvant
We work with an adjuvant (added ingredient) that is combined with our nanoparticle technology. It includes a natural ingredient that comes from the bark of a Chilean tree. Adjuvants are used to help create a stronger immune response in your body.
We are a
biotechnology company
solely devoted to innovating
safe technology.
The Novavax
Commitment
Our technology works to help stimulate an immune response to certain viruses.
Our work makes use of well-established technology that is tailored to enhance an immune response and help protect against certain diseases.
Our goal is to help create solutions rapidly and on a large scale to help people around the globe.
